comparemela.com
  1. Home
  2. Live Updates
  3. Tushar Manudhane - Breaking News

Page 2 - Tushar Manudhane News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Nirma s acquisition of majority stake in Glenmark Life Sciences to make Glenmark Pharma debt-free

Glenmark Pharmaceuticals has entered into a share purchase agreement with Nirma Limited to divest a 75% stake in Glenmark Lifesciences at a price of Rs 615 per share.

Republic ofNorthern samarAbdulkader puranwalaPoornima vardhanDhiren patelRohan johnGlenmark pharmaSalil kallianpurTushar manudhaneStericon pharmaGlenn saldanhaTaponeel mukherjeeGlenmark lifesciencesAculife healthcare pvt ltdContract developmentNirma group

Blackstone bid for Cipla: Experts say there may not be significant change in strategy

Reports suggest the PE giant could make a bid next week for the promoters’ stake, which is valued at $3.8 billion

United statesUnited kingdomYusuf hamiedMahatma gandhiJawaharlal nehruTushar manudhaneKhwaja abdul hamiedParliamentary standing committee on scienceIndustrial researchSenior congressCouncil of scientificResearch analystMotilal oswal financial services ltdJairam rameshParliamentary standing committeeClimate change

Indian pharma industry poised to tap significant opportunity in US generics market

A patent cliff, when products go off-patent, is approaching and this could help domestic pharma majors

Heet vanGaurang sakareAjanta pharmaTushar manudhaneZydus lifesciencesShweta guptaSun pharmaArvind sharmaAurobindo pharmaShardul amarchand mangaldas coMotilal oswal financial services ltdElara capitalTorrent pharmaPatent cliffZydus lifeMotilal oswal financial services

Decoding Dilip Shanghvi s winning formula for Sun Pharma

Decoding Dilip Shanghvi s winning formula for Sun Pharma
businesstoday.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businesstoday.in Daily Mail and Mail on Sunday newspapers.

United statesSouth africaWest bengalNavroz mahudawalaAalok shanghviPrabhudas lilladherMotilal oswalSubhakanta balDawa bazarMukesh ambaniNeetu chandra sharmaAurobindo pharmaTushar manudhaneParam desaiKirti ganorkarArnav das sharma

Sun Pharma to increase R&D investment in specialty and generics businesses

Firm says its current generics pipeline for the US market includes 97 ANDAs, while 13 new drug applications are awaiting the US FDA's approval

Tushar manudhaneDilip shanghviMotilal oswalSun pharmaSun pharmaceutical industriesNew drug applicationManaging directorR ampd investment

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.